Miransertib
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-19719-5 mg |
| CAS # | 1313881-70-7 |
| Pricing | 5 mg, USD $144.0 |
| Synonyms | ARQ-092 |
| MWt | 432.52 |
| Formula | C₂₇H₂₄N₆ |
| Biological Activity | Miransertib (ARQ-092) is a potent, orally active, selective and allosteric Akt inhibitor with IC50s of 2.7 nM, 14 nM and 8.1 nM for Akt1, Akt2, Akt3, respectively. Miransertib is also a potent the AKT1-E17K mutant protein inhibitor and has the potential for PI3K/AKT-driven tumors and Proteus syndrome research[1]. Miransertib is effective against Leishmania[2]. |
| Purity | 99.33% |